Acquiring Company
Servier
Acquired Company
Day One Biopharmaceuticals
Description
Servier has announced the acquisition of Day One Biopharmaceuticals for $21.50 per share, totaling approximately $2.5 billion. This acquisition is aimed at reinforcing Servier's oncology portfolio and enhancing its capabilities in targeted therapies. The transaction is expected to close in the second quarter of 2026, subject to customary conditions.
Fundz sees it the moment Servier makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Day One Biopharmaceuticals?
Day One Biopharmaceuticals was acquired by Servier, based in Suresnes. The deal was reported on March 6, 2026. We firmly believe that by working with patients, at all stages of the drug life cycle, they will benefit from the most suitable therapeutic solution and the best possible care pathway. Servier is privately held and operates in Pharmaceutical Manufacturing.
When did Servier acquire Day One Biopharmaceuticals?
Servier's acquisition of Day One Biopharmaceuticals was reported on March 6, 2026. Servier has announced the acquisition of Day One Biopharmaceuticals for $21.50 per share, totaling approximately $2.5 billion. This acquisition is aimed at reinforcing Servier's oncology portfolio and enhancing its capabilities in targeted therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Day One Biopharmaceuticals do?
Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases. It is privately held, operating in Biotechnology, and is based in Brisbane.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.